Northwest Biotherapeutics (NWBO) Research & Development (2009 - 2026)
Northwest Biotherapeutics (NWBO) posted Research & Development of $5.71 million for Q2 2026, down 23.2% from $7.43 million a year earlier but up 17.4% from the prior quarter.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Northwest Biotherapeutics was $23.57 million, down 31.6% year-over-year; for FY2025, it was $28.79 million, down 17.5% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -3.1% (FY2020 to FY2025).
- In prior years, Northwest Biotherapeutics' Research & Development was $34.89 million in FY2024 (+25.8%), $27.73 million in FY2023 (-21.9%), $35.51 million in FY2022 (+74.9%) and $20.31 million in FY2021 (-39.6%).
- Quarterly Research & Development has run from a low of $3.75 million in Q3 2021 to a high of $13.65 million in Q2 2022 over five years.
- On a year-over-year basis, Research & Development has declined in each of the last five quarters, with an average decline of 9.0% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2022, with growth of 150.3%; the weakest was Q3 2021, with a decline of 78.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $4.86 million (Q1 2026), $5.55 million (Q4 2025) and $7.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Northwest Biotherapeutics | 283.78 Mn | 273.80 Mn | - | 5.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.71 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 7.45 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 10.52 Mn |
| Sep 30, 2024 | 8.13 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | 7.94 Mn |
| Dec 31, 2023 | 7.45 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 6.21 Mn |
| Mar 31, 2023 | 6.86 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 7.69 Mn |
| Jun 30, 2022 | 13.65 Mn |
| Mar 31, 2022 | 4.82 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | 3.75 Mn |
API Access
Northwest Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();